DrugApr 13, 2022
Adamis Pharmaceuticals SYMJEPI recall — FDA D-0764-2022
Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
Class IFDA: TerminatedAdamis Pharmaceuticals Corporation
Recall history in this database
Classification mix: Class I: 2.
DrugApr 13, 2022
Adamis Pharmaceuticals SYMJEPI recall — FDA D-0763-2022
Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
Class IFDA: TerminatedAdamis Pharmaceuticals Corporation
Understanding this recall history
This page summarizes recall records in which the official source identifies Adamis Pharmaceuticals Corporation as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.